BioNTech (BNTX) Downgraded by Zacks Investment Research to Hold

BioNTech} stock has undergone multiple analysts rating changes in the recent past.  BioNTech Downgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More BioNTech (BNTX) Downgraded by Zacks Investment Research to Hold

BioNTech (NASDAQ:BNTX) Upgraded by Zacks Investment Research to Buy

BioNTech} stock has undergone multiple analysts rating changes in the recent past.  BioNTech Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More BioNTech (NASDAQ:BNTX) Upgraded by Zacks Investment Research to Buy